Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Feb 5 2019

Raynaud Phenomenon

  • Snapshot
    • A 50-year-old man presents to his physician’s office for discolored fingers. He reports that this happens in the cold or when he is emotionally stressed. As he is going through a divorce, he reports this happening more often than not. He reports that there is no pain, but he sometimes feels tightening in his fingers with the discoloration. He has a past medical history of limited scleroderma as well as a family history of Raynaud phenomenon. His physical exam is notable for blue fingertips. He is prescribed a calcium channel blocker for his symptoms.
  • Introduction
    • Clinical definition
      • discoloration in extremities due to exaggerated physiologic response to cold temperatures or emotional stress
      • classification
        • Raynaud disease
          • primary (idiopathic) Raynaud phenomenon is not associated with an underlying disease
        • Raynaud syndrome
          • secondary Raynaud phenomenon is associated with an underlying disease
    • Pathogenesis
      • ↓ blood flow to skin due to exaggerated physiologic response to cold temperatures or emotional stress
        • small vessel vasospasm with impaired vasodilation and increased vasoconstriction
      • phases
        • initially, extremities turn white, indicating ischemia
        • then, extremities turn blue, indicating hypoxia and cyanosis
        • finally, extremities turn pink with re-warming, indicating reperfusion
    • Associated conditions
      • systemic sclerosis or limited scleroderma
      • systemic lupus erythematosus
      • mixed connective tissue disease
      • cryoglobulinemia
      • thromboangiitis obliterans (Buerger disease)
      • juvenile rheumatoid arthritis
  • Epidemiology
    • Demographics
      • Raynaud disease
        • majority of patients with Raynaud phenomenon
        • female > male
        • most commonly < 30 years of age
      • Raynaud syndrome
        • most commonly > 30 years of age
    • Location
      • fingers > toes
    • Risk factors
      • family history
      • autoimmune disease
  • Etiology
    • cold temperatures
    • emotional stress
    • drugs
      • beta blockers
  • Presentation
    • Symptoms
      • attacks of triphasic color changes in extremities with cold temperatures or emotional stress
        • white, blue, then pink or red
        • white and blue phase may be associated with feeling of tightness or pain in severe disease
    • Physical exam
      • may not present with all 3 phases
      • usually in fingers or toes, but can also affect nose, cheeks, or ears
      • may have faint peripheral pulses
      • may have digital ischemia, but this is uncommon
        • ulcers
        • gangrene
  • Studies
    • Labs
      • only indicated if an underlying disease is suspected
    • Making the diagnosis
      • most cases are clinically diagnosed
      • can use cold stimulation test to trigger an attack
        • digits rewarm in > 20 minutes if the patient has Raynaud phenomenon
  • Differential
    • Thromboangiitis obliterans (Buerger disease)
      • distinguishing factor
        • a vasculitis that results in digital necrosis and ischemia
    • Frostbite
      • distinguishing factors
        • the disease does not resolve with rewarming
        • when thawed, patients may have bullae with clear or hemorrhagic fluid
  • Treatment
    • Conservative
      • avoid cold temperatures
        • indication
          • for all patients
        • modalities
          • use of mittens or gloves
      • smoking cessation
        • indication
          • for all patients
    • Medical
      • dihydropyridine-type calcium channel blockers
        • indication
          • for patients refractory to conservative methods
        • drugs
          • nifedipine, nimodipine, nicardipine, or amlodipine
          • dihydropyridines act on vascular smooth muscle
      • phosphodiesterase inhibitors
        • indication
          • for patients refractory to calcium channel blockers
        • drugs
          • sildenafil, vardenafil, or tadalafil
  • Complications
    • Digital ulceration
      • more common with secondary Raynaud syndrome
1 of 0
1 of 1
Private Note

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options